In addition, rise in funding for breast liquid biopsy R&D, favorable initiatives undertaken by governments and global health organizations, and increase in breast cancer liquid biopsy reagents ...

The validation data confirms that the HYLA™ optical sensor tracks real-time patient status with high fidelity. The observed 94.2% accuracy for pCO₂ is a critical achievement, demonstrating concordance ...

To counterbalance this, AI-driven predictive technology is helping clinicians to identify risk early enough for closer ...

This comprehensive 2026 report on Gelatine Sculpt provides an in-depth examination of the Gelatine Sculpt supplement's ...

A machine learning model incorporating functional assessments predicts one-year mortality in older patients with HF and improves risk stratification beyond established scores. Functional status at ...

Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.286 billion during the fourth quarter of 2025, growing 15.9 percent on a reported basis, 14.3 percent on an operational 1 basis and ...

Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.286 billion during the fourth quarter of 2025 ...

Medical device company Boston Scientific (NYSE:BSX) in Q4 CY2025, with sales up 15.9% year on year to $5.29 billion. The ...

Opportunistic infections can contribute to antimicrobial resistance making these infections more severe than would occur otherwise. Some uninvolved pathogens that cause these infections possess ...